4-(3-Chloro-2-thienyl)-1,3-thiazol-2-amine → N-[4-(3-chloro-2-thienyl)-1,3-thiazol-2-yl]-4-propylbenzenesulfonamide

HRID 719343

Reaction equation

HRID 719343 reaction equation
[Cl:1][C:2]1[CH:6]=[CH:5][S:4][C:3]=1[C:7]1[N:8]=[C:9]([NH2:12])[S:10][CH:11]=1.[CH2:13]([C:16]1[CH:21]=[CH:20][C:19]([S:22](Cl)(=[O:24])=[O:23])=[CH:18][CH:17]=1)[CH2:14][CH3:15]>>[Cl:1][C:2]1[CH:6]=[CH:5][S:4][C:3]=1[C:7]1[N:8]=[C:9]([NH:12][S:22]([C:19]2[CH:20]=[CH:21][C:16]([CH2:13][CH2:14][CH3:15])=[CH:17][CH:18]=2)(=[O:24])=[O:23])[S:10][CH:11]=1

Participants

3

Procedure

The title compound was prepared from 4-(3-chloro-2-thienyl)-1,3-thiazol-2-amine and 4-n-propylbenzenesulfonyl chloride as described in the synthetic METHOD B to give a brown-red solid (5.3 mg) with purity >90%. MS (pos) m/z 399.2, 401.2.

Sources & evidence

ORD record
ord-0163f6122d71446a9447c33a0d44fc87
Source dataset
uspto-grants-2006_11
Patent number
US07132436B2

Linked notes

Loading…